1 / 4

Continuous Bioprocessing Market Worth $429.12 million by 2028

Continuous bioprocessing involves manufacturing biopharmaceuticals where continuous unit operations are physically connected with minimal hold volume. Some of the major factors driving the growth of this market include the growing demand for biopharmaceuticals, technological developments in continuous bioprocessing, product launches in the area of continuous bioprocessing, and global initiatives supporting the adoption of biopharmaceuticals.

Chaitanya7
Download Presentation

Continuous Bioprocessing Market Worth $429.12 million by 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ?????????? ??????????????????????? ??????????????????? $429.12 $429.12 ??????? ????????? ?? 2028 ??????????? ????? 2028

  2. Continuous Bioprocessing Market – 2021-2028 Meticulous Research®– a leading global market research company published a research report titled “Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography - Forecast to 2028”.According to this latest publication from Meticulous Research®, the continuous bioprocessing market is expected to grow at a CAGR of 23.0% from $100.75 million in 2021 to $429.12 million by 2028. The growth in the overall continuous bioprocessing market is mainly attributed to the growing demand for biopharmaceuticals, growing development of new technologies and products related to continuous bioprocessing, and rising government support for biopharmaceutical manufacturing. In addition, significant opportunities from emerging Asia- Pacific and Latin American regions and growing approval for personalized medicines further support this market's growth. However, factors such as the high risk of contamination with continuous bioprocessing, the complex and technically unfeasible nature of continuous bioprocessing in downstream processes, and shortage of bioprocessing professionals are expected to hinder the adoption of continuous bioprocessing. Download Free Sample Report Now @ https://www.meticulousresearch.com/download- sample-report/cp_id=5079 Continuous Bioprocessing Market: Future Outlook The global continuous bioprocessing market study presents historical market data in terms of values (2019 and 2020), estimated current data (2021), and forecasts it for 2028– Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography. The study also evaluates industry competitors and analyzes their market share at the global and regional levels. Based on product, the filtration systems and consumables segment accounted for the largest share of the market in 2020. The growing demand for higher standards of filter operations in biopharma manufacturing is one of the major drivers for the growth of this segment. Filter manufacturers are developing filtration technologies for continuous bioprocessing to achieve both separation and purification through a combination of physical removal capabilities of filtration and size exclusion. Based on application, the research and development segment is expected to grow at the highest CAGR during the forecast period. The rising focus of R&D to develop vaccines and suitable therapies for COVID-19 and growing relevance of mAb manufacturing for the treatment of various diseases are driving the market growth. The R&D in cell and gene therapy is also accelerated, with over 900 candidates in clinical studies. Facility expansions of CROs or CDMOs to advance research in these areas are expected to boost market growth. Based on end user, the CDMOs and CROs segment is expected to grow at the highest CAGR during the forecast period. Rising investments in CDMOs and CROs and the gradual shifting of CDMOs from batch to continuous manufacturing are driving the market growth. Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

  3. Continuous Bioprocessing Market – 2021-2028 Speak to our Analysts: https://www.meticulousresearch.com/speak-to- analyst/cp_id=5079 This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and the Middle East & Africa. In 2020, North America commanded the largest share of the global continuous bioprocessing market, followed by Europe and Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The key players operating in the continuous bioprocessing market are 3M (U.S.), Cytiva (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Repligen Corporation (U.S.), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands), Pall Corporation (U.S.), and Bionet (Spain). To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/continuous-bioprocessing-market- 5079 Key questions answered in the report- •What are the high growth market segments in terms of product, application, end user, and region/countries? •What was the historical market for continuous bioprocessing across the globe? •What are the market forecasts and estimates for the period 2021-2028? •What are the major drivers, restraints, challenges, opportunities, and trends in the global continuous bioprocessing market? •Who are the major players in the global continuous bioprocessing market? •How is the competitive landscape, and who are the market leaders in the global continuous bioprocessing market? •What are the recent developments in the global continuous bioprocessing market? •What are the different strategies adopted by the major players in the global continuous bioprocessing market? •What are the geographical trends and high growth regions/countries? Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

  4. Continuous Bioprocessing Market – 2021-2028 Exciting news! We are thrilled to announce an incredible opportunity for you! For a limited time only, we are delighted to offer an exclusive flat 30% discount on all our remarkable research reports. It's our way of showing appreciation for your continuous support and commitment to staying informed. This remarkable discount allows you to unlock a wealth of valuable insights and expert analysis at an unbeatable price. Whether you're a business professional, an academic researcher, or an avid learner, this offer is tailor-made to enhance your knowledge and empower your decision-making. Quick Buy: https://www.meticulousresearch.com/Checkout/13717155 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com

More Related